| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.3M | — | -9.8% |
| R&D Expense | $5.8M | — | +10.5% |
| SG&A Expense | $10.9M | — | -21.8% |
| Operating Income | -$19.4M | — | +10.2% |
| Pre-tax Income | -$20.1M | — | +0.4% |
| Income Tax | -$613K | — | -88.0% |
| Net Income | -$19.5M | — | +1.8% |
| EPS (Basic) | -$0.21 | — | +48.8% |
| EPS (Diluted) | -$0.21 | — | +48.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $15.1M | -45.0% | -6.2% |
| Accounts Receivable | $26.7M | -27.3% | -21.0% |
| Current Assets | $50.5M | -31.7% | -17.7% |
| Total Assets | $155.2M | -14.9% | -22.3% |
| Current Liabilities | $96.3M | -7.2% | +55.1% |
| Total Liabilities | $106.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.5M | — | +32.6% |
| Capital Expenditures | $534K | — | -60.5% |
| Investing Cash Flow | -$534K | — | +60.5% |
| Financing Cash Flow | -$486K | — | -102.7% |
| Free Cash Flow | -$12.0M | — | +34.6% |
| -42.6% |
| Stockholders' Equity | $49.0M | -28.1% | +232.1% |